Liao Q P, Buhimschi I A, Saade G, Chwalisz K, Garfield R E
University of Texas Medical Branch, Department of Obstetrics and Gynecology, Galveston 77555-1062, USA.
Hum Reprod. 1996 Dec;11(12):2777-84. doi: 10.1093/oxfordjournals.humrep.a019209.
Treatment of pregnant rats with the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME), has been shown to produce symptoms similar to pre-eclampsia (i.e. elevated blood pressure, proteinuria and fetal growth retardation). After L-NAME infusion is initiated on day 17 or 18 of gestation, the blood pressure proceeds in a biphasic pattern (immediate rise, followed by a decline, then increasing again in the post-partum period). The blood pressure actually begins to rise prior to delivery on days 21-22, i.e. after progesterone withdrawal occurs, suggesting that these responses may be regulated by changes in steroid hormone concentrations during pregnancy. Therefore, we evaluated the effects of the different steroid hormones: progestins (progesterone, promegestone, levonorgestrel), antiprogestins (mifepristone), 17 beta-oestradiol or androgens (testosterone, dihydrotestosterone) on systolic blood pressure in pregnant, non-pregnant female and normal male rats with and without L-NAME treatment and spontaneously hypertensive male rats. The animals received continuous infusions of L-NAME (150 mg/kg/day) or vehicle through osmotic mini-pumps and daily s.c. injections of steroid hormones. In pregnant rats the pump was inserted on day 17 or 18 of gestation and steroid hormone injections were started on the first day following delivery at term and continued daily until post-partum day 10. In non-pregnant female or male rats steroid hormone injections were initiated 5 days after the L-NAME pump was inserted. Systolic blood pressure was measured daily from the tail with a pneumatic tail-cuff device. R5020 (1.5 mg/kg/day) significantly attenuated the blood pressure elevation induced by L-NAME during the post-partum period. Similarly, it lowered blood pressure in L-NAME treated non-pregnant female rats or male rats. R5020 also lowered blood pressure in spontaneously hypertensive male rats. Progesterone (6 mg/kg/day) had similar effects on blood pressure in the post-partum period, although it also lowered the blood pressure in control animals. Interestingly, administration of two different doses of levonorgestrel (0.3 and 1.5 mg/kg/day) did not decrease the blood pressure in either L-NAME-infused rats or controls. Mifepristone (RU486, 30 mg/kg/day) further increased blood pressure in L-NAME-treated rats post-partum. 17 beta-oestradiol (30 micrograms/kg/day) had no effect on blood pressure in either L-NAME infused rats in the post-partum period or controls, whereas both testosterone (0.3 mg/kg/day) and dihydrotestosterone (0.3 mg/kg/day) significantly attenuated the blood pressure increase after L-NAME, while raising the blood pressure in vehicle-infused animals. These results suggest that the control of systemic blood pressure during pregnancy may be modulated by steroid hormones. Progesterone may be the steroid hormone with the major action on vascular tension during pregnancy.
用一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)处理妊娠大鼠,已显示会产生类似于先兆子痫的症状(即血压升高、蛋白尿和胎儿生长受限)。在妊娠第17或18天开始输注L-NAME后,血压呈双相模式(立即升高,随后下降,然后在产后时期再次升高)。血压实际上在分娩前的第21 - 22天就开始升高,即在孕酮撤退后,这表明这些反应可能受孕期类固醇激素浓度变化的调节。因此,我们评估了不同类固醇激素:孕激素(孕酮、普美孕酮、左炔诺孕酮)、抗孕激素(米非司酮)、17β-雌二醇或雄激素(睾酮、双氢睾酮)对妊娠、未妊娠雌性和正常雄性大鼠(有无L-NAME处理)以及自发性高血压雄性大鼠收缩压的影响。动物通过渗透微型泵持续输注L-NAME(150 mg/kg/天)或溶剂,并每天皮下注射类固醇激素。在妊娠大鼠中,泵在妊娠第17或18天插入,类固醇激素注射在足月分娩后的第一天开始,并持续每天注射直至产后第10天。在未妊娠雌性或雄性大鼠中,类固醇激素注射在插入L-NAME泵5天后开始。每天用气动尾袖装置从尾部测量收缩压。R5020(1.5 mg/kg/天)在产后时期显著减轻了L-NAME诱导的血压升高。同样,它降低了L-NAME处理的未妊娠雌性大鼠或雄性大鼠的血压。R5020也降低了自发性高血压雄性大鼠的血压。孕酮(6 mg/kg/天)在产后时期对血压有类似作用,尽管它也降低了对照动物的血压。有趣的是,给予两种不同剂量的左炔诺孕酮(0.3和1.5 mg/kg/天)在输注L-NAME的大鼠或对照中均未降低血压。米非司酮(RU486,30 mg/kg/天)在产后使L-NAME处理的大鼠血压进一步升高。17β-雌二醇(30 μg/kg/天)在产后对输注L-NAME的大鼠或对照的血压均无影响,而睾酮(0.3 mg/kg/天)和双氢睾酮(0.3 mg/kg/天)均显著减轻了L-NAME后的血压升高,同时使输注溶剂的动物血压升高。这些结果表明孕期全身血压的控制可能受类固醇激素调节。孕酮可能是孕期对血管张力起主要作用的类固醇激素。